Cover Image
市場調查報告書

全球miRNA市場預測

Global miRNA Market Outlook to 2020

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 341901
出版日期 內容資訊 英文 130 Pages
訂單完成後即時交付
價格
Back to Top
全球miRNA市場預測 Global miRNA Market Outlook to 2020
出版日期: 2015年10月01日 內容資訊: 英文 130 Pages
簡介

微型核糖核酸 (miRNA) ,在疾病、組織重塑,成為發揮特別重要作用的細胞過程的強力的調節遺傳基因。在全世界的癌症、心血管疾病、肝疾病、神經疾病等各種慢性疾病的臨床試驗,進行miRNA的治療相關可能性的評價。

本報告提供全球miRNA市場相關調查分析、現況與展望、主要推動因素與課題、主要企業等相關的系統性資訊。

第1章 分析師的見解

第2章 調查手法

第3章 miRNA:概要

第4章 miRNA技術

  • 煉製
  • 標籤
  • 線性擴增
  • 微陣列
  • 定量即時PCR
  • 抑制
  • 轉染

第5章 產業概要

  • 推動市場要素
  • 市場機會
  • 市場課題
  • 市場趨勢

第6章 全球miRNA市場預測

  • miRNA工具與服務市場

第7章 全球miRNA市場:各應用

  • 研究
  • 診斷
  • 醫藥品開發

第8章 全球miRNA市場:各終端用戶

  • 研究所、機關
  • 生物產業
  • 醫院、診斷中心

第9章 全球miRNA市場:各地區

  • 南北美洲
  • 歐洲
  • 亞太地區

第10章 全球miRNA市場:各疾病

  • 簡介
  • 癌症
  • 神經疾病
  • 心血管疾病
  • 肝疾病
  • 其他

第11章 miRNA途徑的醫藥品候補的組合

第12章 主要企業

  • QIAGEN
  • Sigma-Aldrich Corporation (Merck KGaA的子公司)
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies Inc.
  • Affymetrix
  • Integrated DNA Technologies
  • Exiqon
  • Mirus Bio LLC
  • 和光純藥工業
  • Rosetta Genomics Ltd.

圖表

目錄

miRNAs have risen as powerful regulators of different cellular processes with specifically important roles in disease and tissue remodelling. The miRNA is widely used in researches for identifying new application areas of its use. With respect to this, there are various clinical trials being organized throughout the world so as to evaluate the therapeutic potential of miRNA in curing various chronic diseases such as cancer, cardiovascular diseases, hepatic disorders, neurological disorders, and so forth. The report, Global miRNA Market Outlook to 2020, provides an overview of the current state of the miRNA market, focusing mainly on continuing research endeavors, emerging tools, reagents, techniques, diagnostics, and therapeutic products. Forecast projections are provided for the period, 2015 to 2020.

Brief information about the two major segmentation of miRNA market, i.e., tools and services, have been provided in the report. The former consists of different tools that are utilized to study miRNA including PCR arrays, labels, isolation kits, mimics, inhibitors, and markers. On the other hand, the latter includes various services such as purification, expression profiling, quantification, and analysis that are offered by miRNA players.

Based on diseases in which miRNA tools are used, the report provides insights about cancer, cardiovascular diseases, hepatic disorders, neurological disorders, and other diseases. The report provides the current as well as the forecasted market for miRNA use in each of diseases.

The report also segments the market based on the end users of these miRNA tools and services. The end users of the miRNA tools and services include research labs and institutes, biotechnology and biopharmaceutical industries, and hospitals and diagnostic centers. Detailed information regarding the current market size and the year-on-year forecasted markets is provided for each end user.

Based on geography, the miRNA market has been categorized into three segments: The Americas, Europe, and Asia Pacific. These regions have then been investigated for analyzing the current research and industrial applications of miRNAs. An in-depth analysis of the market recommends that cancer is the most researched subject out of neurodegenerative, cardiovascular, hepatic, and other chronic diseases. United States, France, Germany, United Kingdom, China, Israel, and Korea are the significant players interested in assessing the potential of miRNA.

The miRNA tools and services find major application in research area. Other major application areas of miRNA include diagnostics and drug development. The report provides the share of each application for 2014.

The major players in the miRNA market include Qiagen (Germany), Sigma-Aldrich Corporation (US), Thermo Fisher Scientific Inc. (US), Agilent Technologies Inc. (US), Affymetrix, (US), Integrated DNA Technologies (US), Exiqon (Denmark), Mirus Bio LLC (US), Wako Pure Chemical Industries (Japan), and Rosetta Genomics Ltd. (Israel). These players are working over a wide range of products including miRNA extraction and purification kits, and miRNA mimics and inhibitors, and are consistently redesigning & updating their portfolio to stay connected and updated with the most recent advancements in the field.

Table of Contents

1. Analyst View

2. Research Methodology

3. miRNA - An Introduction

4. miRNA Techniques

  • 4.1. miRNA Purification
  • 4.2. miRNA Labeling
  • 4.3. miRNA Linear Amplification
  • 4.4. miRNA Microarrays
  • 4.5. miRNA qRT-PCR
  • 4.6. miRNA Inhibition
  • 4.7. miRNA Transfection

5. Industry Overview

  • 5.1. Market Drivers
    • 5.1.1. Growing Focus on Developing of miRNA-based Diagnostic Biomarkers
    • 5.1.2. Technological Advancements
    • 5.1.3. Rise in miRNA-based Researches
    • 5.1.4. Increasing Prevalence of Chronic Diseases
    • 5.1.5. Rising Investments in miRNA Market
  • 5.2. Market Opportunities
    • 5.2.1. Increasing miRNA-based Research in Cardiovascular Biology and Disease
    • 5.2.2. Therapeutics Application Offers Significant Growth Opportunity
  • 5.3. Market Challenges
    • 5.3.1. High Cost of developing miRNA-based Tools
    • 5.3.2. Technological Challenges in Developing miRNA-based Therapeutics
  • 5.4. Market Trends
    • 5.4.1. Increasing Strategic Alliances in the Market
    • 5.4.2. Next Generation Sequencing: Gaining Momentum

6. Global miRNA Market Outlook to 2020

  • 6.1. miRNA Tools and Services Market

7. Global miRNA Market by Applications

  • 7.1. Research
  • 7.2. Diagnostics
  • 7.3. Drug Development

8. Global miRNA Market by End User

  • 8.1. Research Labs and Institutes
  • 8.2. Biotechnology Industry
  • 8.3. Hospitals and Diagnostic Centers

9. Global miRNA Market by Geography

  • 9.1. The Americas
  • 9.2. Europe
  • 9.3. Asia Pacific (APAC)

10. Global miRNA Market, by Disease

  • 10.1. Introduction
  • 10.2. Cancer
  • 10.3. Neurological Diseases
  • 10.4. Cardiovascular Diseases
  • 10.5. Hepatic Diseases
  • 10.6. Other Diseases

11. Portfolio of miRNA Pathway Drugs Candidates

12. Key Players

  • 12.1. QIAGEN
  • 12.2. Sigma-Aldrich Corporation (A Subsidiary of Merck KGaA)
  • 12.3. Thermo Fisher Scientific, Inc.
  • 12.4. Agilent Technologies Inc.
  • 12.5. Affymetrix
  • 12.6. Integrated DNA Technologies
  • 12.7. Exiqon
  • 12.8. Mirus Bio LLC
  • 12.9. Wako Pure Chemical Industries
  • 12.10. Rosetta Genomics Ltd.

List of Figures:

  • Figure 5-1: Workflow of a miRNA Next-Generation Sequencing Experiment
  • Figure 6-1: Global - miRNA Market (Million US$), 2014-2020
  • Figure 6-2: Global - miRNA Tools Market (Million US$), 2014-2020
  • Figure 6-3: Global - miRNA Services Market (Million US$), 2014-2020
  • Figure 7-1: Global - miRNA Market by Applications (%), 2014
  • Figure 7-2: Number of miRNAs in the miRBase Database, (2002-2014)
  • Figure 7-3: Number of Registered miRNAs for Various Types of Cancers, (2015)
  • Figure 8-1: Global - miRNA Research Labs & Institutes Market (Million US$), 2014-2020
  • Figure 8-2: Global - miRNA Biotechnology Industry Market (Million US$), 2014-2020
  • Figure 8-3: Global - miRNA Hospitals & Diagnostic Center Market (Million US$), 2014-2020
  • Figure 9-1: The Americas - miRNA Market (Million US$), 2014-2020
  • Figure 9-2: The Americas - Ongoing miRNA Research by Country (%), 2015
  • Figure 9-3: The Americas - Ongoing miRNA Research by Disease (%), 2015
  • Figure 9-4: Europe - miRNA Market (Million US$), 2014-2020
  • Figure 9-5: Europe - Ongoing miRNA Research by Country (%), 2015
  • Figure 9-6: Europe - Ongoing miRNA Research by Disease (%), 2015
  • Figure 9-7: Asia Pacific - miRNA Market (Million US$), 2014-2020
  • Figure 9-8: Asia Pacific - Ongoing miRNA Research by Country (%), 2015
  • Figure 9-9: Asia Pacific - Ongoing miRNA Research by Disease (%), 2015
  • Figure 10-1: Global - miRNA Market by Application (%), 2014
  • Figure 10-2: Global - miRNA Cancer Market (Million US$), 2014-2020
  • Figure 10-3: Global - miRNA Neurological Diseases Market (Million US$), 2014-2020
  • Figure 10-4: Global - miRNA Cardiovascular Diseases Market (Million US$), 2014-2020
  • Figure 10-5: Global - miRNA Hepatic Diseases Market (Million US$), 2014-2020
  • Figure 10-6: Global - miRNA Other Diseases Market (Million US$), 2014-2020
  • Figure 11-1: Major miRNA Clinical Candidates

List of Tables:

  • Table 4-1: miRNA Purification Products by Supplier
  • Table 4-2: miRNA Labeling Products by Supplier
  • Table 4-3: miRNA Linear Amplification Products by Supplier
  • Table 4-4: miRNA Microarray Products by Supplier
  • Table 4-5: miRNA qRT-PCR Products by Supplier
  • Table 4-6: miRNA Inhibition Products by Supplier
  • Table 4-7: miRNA Transfection Products by Supplier
  • Table 5-1: Potential miRNAs for Therapeutic Application
  • Table 9-1: The Americas - miRNA Research (2005-September, 2015)
  • Table 9-2: Europe - miRNA Research (2005-September, 2015)
  • Table 9-3: Asia Pacific - miRNA Research (2005-September, 2015)
  • Table 10-1: miRNAs Associated with Common Human Diseases
  • Table 10-2: miRNAs Associated with Cancer
  • Table 10-3: miRNAs Associated with Cardiovascular Disorders
  • Table 10-4: miRNAs Associated with Hepatitis
  • Table 11-1: Major Players in miRNA Diagnostics & Therapeutics Applications
  • Table 12-1: Qiagen - miRNA Associated Product Line
  • Table 12-2: Sigma Aldrich - miRNA Associated Product Line
  • Table 12-3: Thermo Fisher - miRNA Associated Product Line
  • Table 12-4: Agilent - miRNA Associated Product Line
  • Table 12-5: Affymetrix - miRNA Associated Product Line
  • Table 12-6: IDT - miRNA Associated Product Line
  • Table 12-7: Exiqon - miRNA Associated Product Line
  • Table 12-8: Mirus Bio - miRNA Associated Product Line
  • Table 12-9: Wako - miRNA Associated Product Line
  • Table 12-10 Rosetta Genomics- miRNA Associated Product Line
Back to Top